H. E. M. Kay

5.6k citations

86 papers · 4.0k · h-index 31

Impact in

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 29
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 11
- Blood groups and transfusion 6
- Chronic Myeloid Leukemia Treatments 5
Public Health, Environmental and Occupational Health 21
- Acute Lymphoblastic Leukemia research 21

Co-authors: Beryl Jameson (12 shared papers)T J McElwain (11 shared papers)R Powles (10 shared papers)Melvyn F. Greaves (4 shared papers)H.M. Clink (7 shared papers)G Jánossy (3 shared papers)Julian Peto (3 shared papers)J.G. Watson (7 shared papers)
Journals: The Lancet (28 papers)British Journal of Haematology (14 papers)Journal of Clinical Pathology (5 papers)Archives of Disease in Childhood (3 papers)Cancer (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

H. E. M. Kay

83 papers receiving 3.4k citations

Peers

Replace E. Donnall Thomas with:

E. Donnall Thomas United States

Alexander Fefer United States

Good Ra United States

Jaak M. Vossen Netherlands

R Miniero Italy

Hans A. Messner Canada

A Oakhill United Kingdom

Wilma Β. Bias United States

Morton J. Cowan United States

Martin Stern Switzerland

H. E. M. Kay relative to E. Donnall Thomas United States E. Donnall Thomas's profile →

Citations per field

00.5×1.5×2.1×

E. Donnall Thomas · 1×

×0.5 2k/3k

HEMAT

×0.9 707/798

GENET

×0.6 157/244

TRANS

×0.8 1k/1k

IMMUN

×2.1 838/394

PHEOH

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by H. E. M. Kay

Since Specialization

Citations

This map shows the geographic impact of H. E. M. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. M. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. M. Kay more than expected).

Fields of papers citing papers by H. E. M. Kay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. M. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. M. Kay. The network helps show where H. E. M. Kay may publish in the future.

Co-authors

The 25 scholars most cited alongside H. E. M. Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. E. M. Kay Line = papers co-authored together H. E. M. Kay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION The Lancet ·R Powles, H.M. Clink, David J. Spence, G.R. Morgenstern, J.G. Watson, P Selby, Mary Woods, Ann Barrett, Beryl Jameson, John Sloane, S. D. Lawler, H. E. M. Kay, D. Lawson, T J McElwain, Peter Alexander	1980	316
2	Risk factors for acute graft‐versus‐host disease British Journal of Haematology ·Robert Peter Gale, Mortimer M. Bortin, D. W. van Bekkum, J. C. Biggs, Karel A. Dicke, Eliane Gluckman, Robert A. Good, Raymond G. Hoffmann, H. E. M. Kay, John H. Kersey, Alberto M. Marmont, Tohru Masaoka, Alfred A. Rimm, Jon J. van Rood, F. Zwaan	1987	274
3	DESIGN AND USE OF PLASTIC TENTS FOR ISOLATION OF PATIENTS PRONE TO INFECTION The Lancet ·A Robertson, J. Lynch, H. E. M. Kay, Beryl Jameson, R. J. GUYER, I. L. Evans	1968	237
4	Immunologically Defined Subclasses of Acute Lymphoblastic Leukaemia in Children: their Relationship to Presentation Features and Prognosis British Journal of Haematology ·Melvyn F. Greaves, G Jánossy, Julian Peto, H. E. M. Kay	1981	233
5	MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA The Lancet ·R Powles, H. E. M. Kay, H.M. Clink, A. John Barrett, Michael H. Depledge, John Sloane, H. Lumley, S. D. Lawler, G.R. Morgenstern, T J McElwain, P J Dady, Beryl Jameson, J.G. Watson, Margaret W. Leigh, David W. Hedley, Jacqueline Filshie, Bridget A. Robinson	1983	196
6	Encephalopathy in Acute Leukaemia Associated with Methotrexate Therapy Archives of Disease in Childhood ·H. E. M. Kay, P. J. Knapton, J. P. O’Sullivan, David G. Wells, Rosemarie Harris, E M Innes, J. Stuart, F. C. M. Schwartz, E. N. Thompson	1972	194
7	FŒTAL THYMIC TRANSPLANT IN A CASE OF DiGEORGE'S SYNDROME The Lancet ·W W Cleveland, Bernard J. Fogel, W. Ted Brown, H. E. M. Kay	1968	176
8	CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN The Lancet ·R Powles, H.M. Clink, John Sloane, A. John Barrett, H. E. M. Kay, T J McElwain	1978	159
9	THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA The Lancet ·R Powles, H.M. Clink, Giuseppe Bandini, J.G. Watson, David J. Spence, Beryl Jameson, H. E. M. Kay, G.R. Morgenstern, David W. Hedley, H. Lumley, D. Lawson, A. John Barrett, S. D. Lawler, T J McElwain	1980	150
10	Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases British Journal of Haematology ·George Janossy, A. V. Hoffbrand, Melvyn F. Greaves, K. Ganeshaguru, Carol Pain, Kenneth F. Bradstock, H. G. Prentice, H. E. M. Kay, T. Andrew Lister	1980	133
11	PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MAN The Lancet ·Peter J. Selby, Beryl Jameson, J.G. Watson, G.R. Morgenstern, R Powles, H. E. M. Kay, Ruth B. Thornton, H.M. Clink, T J McElwain, H. G. Prentice, M G Ross, Robert Corringham, A. V. Hoffbrand, D. Brigden	1979	132
12	IMPLANTATION OF A FŒTAL THYMUS, RESTORING IMMUNOLOGICAL COMPETENCE IN A PATIENT WITH THYMIC APLASIA (DiGEORGE'S SYNDROME) The Lancet ·Charles S. August, Fred S. Rosen, Robert M. Filler, Charles A. Janeway, B Markowski, H. E. M. Kay	1968	131
13	Hereditary lymphopenic agammaglobulinemia associated with a distinctive form of short-limbed dwarfism and ectodermal dysplasia The Journal of Pediatrics ·Richard A. Gatti, Norbert Platt, Herbert H. Pomerance, Richard Hong, Leonard O. Langer, H. E. M. Kay, Robert A. Good	1969	98
14	Immunosuppressive Consequences of Radiotherapy and Chemotherapy in Patients with Acute Lymphoblastic Leukaemia BMJ ·Amity Campbell, Peter Hersey, I. C. M. MacLennan, H. E. M. Kay, M. C. Pike	1973	78
15	The Chromosomes in Polycythaemia Vera British Journal of Haematology ·H. E. M. Kay, Sylvia D. Lawler, Rosemary E. Millard	1966	78
16	Analysis of treatment in childhood leukemia. IV.The critical association between dose fractionation and immunosuppression induced by cranial irradiation Cancer ·(unknown), I. C. M. MacLennan, H. E. M. Kay	1978	74
17	L-Asparaginase in Treatment of Acute Leukaemia and Lymphosarcoma BMJ ·M. E. J. Beard, D. Crowther, D. A. G. Galton, Rachel Guyer, G. Hamilton Fairley, H. E. M. Kay, P. J. Knapton, J. S. Malpas, Ronald Bodley Scott	1970	70
18	ACID-PHOSPHATASE REACTION IN ACUTE LYMPHOBLASTIC LEUKÆMIA The Lancet ·Daniel Catovsky, Melvyn F. Greaves, Carol Pain, Maria Valeria Cherchi, G Jánossy, H. E. M. Kay	1978	70
19	Agglutination of platelets by a serum factor in the presence of EDTA Journal of Clinical Pathology ·E Gowland, H. E. M. Kay, Judy C. Spillman, Joseph R. Williamson	1969	63
20	FAMILIAL LYMPHOPENIA WITH AGAMMAGLOBULINÆMIA The Lancet ·W. H. Hitzig, H. E. M. Kay, H. Cottier	1965	63

About H. E. M. Kay

H. E. M. Kay is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Immunology, having authored 86 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (21 papers), Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers), Neutropenia and Cancer Infections (11 papers), Immunodeficiency and Autoimmune Disorders (9 papers), Blood groups and transfusion (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (707 citations), Transplantation (157 citations), Immunology (1.1k citations) and Public Health, Environmental and Occupational Health (838 citations). H. E. M. Kay has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Beryl Jameson, T J McElwain, R Powles, Melvyn F. Greaves, H.M. Clink, G Jánossy, Julian Peto, J.G. Watson, G.R. Morgenstern and Sylvia D. Lawler. Their work appears in journals such as The Lancet, British Journal of Haematology, Journal of Clinical Pathology, Archives of Disease in Childhood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

H. E. M. Kay

Impact in

Papers in i

In The Last Decade

H. E. M. Kay

Peers

Countries citing papers authored by H. E. M. Kay

Fields of papers citing papers by H. E. M. Kay

All Works

About H. E. M. Kay

Explore authors with similar magnitude of impact

Papers in